Patient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction
- 15 February 2021
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 77 (7), 848-857
- https://doi.org/10.1016/j.jacc.2020.12.034
Abstract
No abstract availableFunding Information
- Novartis Pharmaceuticals Corporation
- Janssen Biotech
- Boehringer Ingelheim
- Abbott Fund
- Merck
- American Heart Association (18 CDA 34110215)
- Amgen
- Takeda Pharmaceuticals U.S.A.
- Bayer Fund
- AbbVie
- Cytokinetics
- Pfizer
- National Institutes of Health
- Novartis
- National Center for Advancing Translational Sciences
This publication has 27 references indexed in Scilit:
- Causes of Elevated Cardiac Troponins in the Emergency Department and Their Associated MortalityAcademic Emergency Medicine, 2016
- Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injuryHeart, 2016
- Clinical Characteristics and Outcomes of Patients with Myocardial Infarction, Myocardial Injury, and Nonelevated TroponinsThe American Journal of Medicine, 2015
- Sensitive Troponin Assay and the Classification of Myocardial InfarctionThe American Journal of Medicine, 2014
- Clinical characteristics, aetiology and occurrence of type 2 acute myocardial infarctionKardiologia Polska, 2014
- Type-II Myocardial Infarction – Patient Characteristics, Management and OutcomesPLOS ONE, 2014
- Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial InfarctionThe American Journal of Medicine, 2013
- The impact of the 2007 ESC–ACC–AHA–WHF Universal definition on the incidence and classification of acute myocardial infarction: A retrospective cohort studyInternational Journal of Cardiology, 2008
- Universal Definition of Myocardial InfarctionCirculation, 2007
- ACUTE MYOCARDIAL INFARCTION NOT DUE TO CORONARY ARTERY OCCLUSIONJournal of the American Medical Association, 1939